Galena Biopharma - 53 Year Dividend History | SLS

Historical dividend payout and yield for Galena Biopharma (SLS) since 1971. The current TTM dividend payout for Galena Biopharma (SLS) as of April 18, 2024 is $0.00. The current dividend yield for Galena Biopharma as of April 18, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.079B $0.001B
SELLAS Life Sciences Group is a development-stage biopharmaceutical company. It focused on novel cancer immunotherapeutics for cancer indications. The company's product candidate, galinpepimut-S, is licensed from Memorial Sloan Kettering Cancer Center and targets the Wilms Tumor 1 protein, which is present in an array of tumor types. SELLAS Life Sciences Group Inc., formerly known as Galena Biopharma Inc., is based in NEW YORK, United States.
Stock Name Country Market Cap PE Ratio